investors.glaukos.com investors.glaukos.com

investors.glaukos.com

Glaukos Corporation - INVESTORS

August 12, 2015. Glaukos Corporation Announces Second Quarter 2015 Financial Results. August 10, 2015. Health Canada Approves the Glaukos iStent inject. August 6, 2015. Glaukos Corporation Announces Completion of Patient Enrollment in U.S. Pivotal Clinical Trial for iStent inject. There are no events scheduled at this time. 26051 Merit Circle, Suite 103. Laguna Hills, CA 92653. Telephone: 949.367.9600 ext 371. Fax: 949.367.9984. 26051 Merit Circle, Suite 103, Laguna Hills, CA 92653.

http://investors.glaukos.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.GLAUKOS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

June

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.7 out of 5 with 11 reviews
5 star
4
4 star
4
3 star
1
2 star
0
1 star
2

Hey there! Start your review of investors.glaukos.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.8 seconds

FAVICON PREVIEW

  • investors.glaukos.com

    16x16

  • investors.glaukos.com

    32x32

CONTACTS AT INVESTORS.GLAUKOS.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Glaukos Corporation - INVESTORS | investors.glaukos.com Reviews
<META>
DESCRIPTION
August 12, 2015. Glaukos Corporation Announces Second Quarter 2015 Financial Results. August 10, 2015. Health Canada Approves the Glaukos iStent inject. August 6, 2015. Glaukos Corporation Announces Completion of Patient Enrollment in U.S. Pivotal Clinical Trial for iStent inject. There are no events scheduled at this time. 26051 Merit Circle, Suite 103. Laguna Hills, CA 92653. Telephone: 949.367.9600 ext 371. Fax: 949.367.9984. 26051 Merit Circle, Suite 103, Laguna Hills, CA 92653.
<META>
KEYWORDS
1 migs
2 istent
3 patients
4 physicians
5 about glaukos
6 investors
7 stock information
8 stock quote
9 stock chart
10 historical price lookup
CONTENT
Page content here
KEYWORDS ON
PAGE
migs,istent,patients,physicians,about glaukos,investors,stock information,stock quote,stock chart,historical price lookup,financials and filings,sec filings,corporate governance,governance documents,management team,board of directors,committee composition
SERVER
NA
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Glaukos Corporation - INVESTORS | investors.glaukos.com Reviews

https://investors.glaukos.com

August 12, 2015. Glaukos Corporation Announces Second Quarter 2015 Financial Results. August 10, 2015. Health Canada Approves the Glaukos iStent inject. August 6, 2015. Glaukos Corporation Announces Completion of Patient Enrollment in U.S. Pivotal Clinical Trial for iStent inject. There are no events scheduled at this time. 26051 Merit Circle, Suite 103. Laguna Hills, CA 92653. Telephone: 949.367.9600 ext 371. Fax: 949.367.9984. 26051 Merit Circle, Suite 103, Laguna Hills, CA 92653.

INTERNAL PAGES

investors.glaukos.com investors.glaukos.com
1

Glaukos Corporation - Investors - Investor Overview

http://investors.glaukos.com/Investors/Investor-Resources/Email-Alerts/default.aspx

Symptoms and Risk Factors. Micro-Invasive Glaucoma Surgery (MIGS). What To Expect With iStent. Symptoms and Risk Factors. Micro-Invasive Glaucoma Surgery (MIGS). What To Expect With iStent. Our first MIGS device, in the United States in July 2012 and we are leveraging our platform technology to build a comprehensive and proprietary portfolio of micro-scale injectable therapies designed to address the complete range of glaucoma disease states and progression. We believe the iStent. October 31, 2016. Glauk...

2

Glaukos Corporation - Investors - Investor Overview

http://investors.glaukos.com/Investors/Investor-Resources/FAQs/default.aspx

Symptoms and Risk Factors. Micro-Invasive Glaucoma Surgery (MIGS). What To Expect With iStent. Symptoms and Risk Factors. Micro-Invasive Glaucoma Surgery (MIGS). What To Expect With iStent. Our first MIGS device, in the United States in July 2012 and we are leveraging our platform technology to build a comprehensive and proprietary portfolio of micro-scale injectable therapies designed to address the complete range of glaucoma disease states and progression. We believe the iStent. October 31, 2016. Glauk...

3

Glaukos Corporation - Investors - Investor Overview

http://investors.glaukos.com/Investors/Investor-Resources/Investor-Resources/default.aspx

Symptoms and Risk Factors. Micro-Invasive Glaucoma Surgery (MIGS). What To Expect With iStent. Symptoms and Risk Factors. Micro-Invasive Glaucoma Surgery (MIGS). What To Expect With iStent. Our first MIGS device, in the United States in July 2012 and we are leveraging our platform technology to build a comprehensive and proprietary portfolio of micro-scale injectable therapies designed to address the complete range of glaucoma disease states and progression. We believe the iStent. October 31, 2016. Glauk...

4

Glaukos Corporation - Investors - Corporate Governance - Management Team

http://investors.glaukos.com/Investors/Corporate-Governance/Management-Team/default.aspx

Symptoms and Risk Factors. Micro-Invasive Glaucoma Surgery (MIGS). What To Expect With iStent. Symptoms and Risk Factors. Micro-Invasive Glaucoma Surgery (MIGS). What To Expect With iStent. Thomas W. Burns. President, Chief Executive Officer. Chris M. Calcaterra. Richard L. Harrison. Robert L. Davis. Senior Vice President, General Counsel. Jeffrey M. Wells. Senior Vice President, Regulatory, Quality and Clinical Affairs. Michele M. Allegretto. Vice President, Human Resources. Sheree L. Aronson.

5

Glaukos Corporation - Investors - Corporate Governance - Board of Directors

http://investors.glaukos.com/Investors/Corporate-Governance/Board-of-Directors/default.aspx

Symptoms and Risk Factors. Micro-Invasive Glaucoma Surgery (MIGS). What To Expect With iStent. Symptoms and Risk Factors. Micro-Invasive Glaucoma Surgery (MIGS). What To Expect With iStent. William J. Link. Thomas W. Burns. President, Chief Executive Officer and Director. Mark J. Foley. David F. Hoffmeister. Gilbert H. Kliman. Jonathan T. Silverstein. Marc A. Stapley. Aimee S. Weisner. 26051 Merit Circle, Suite 103. Laguna Hills, CA 92653. Telephone: 949-367-9600 ext 371. DFU and MRI Information.

UPGRADE TO PREMIUM TO VIEW 14 MORE

TOTAL PAGES IN THIS WEBSITE

19

OTHER SITES

investors.getfeedbac.com investors.getfeedbac.com

Investors

Welcome, get to know more about Feedbac. Download the pitch deck. Are you an investor? Enter your invite code. I don't have a code, please send me one.

investors.getfloridagas.com investors.getfloridagas.com

Florida Gas: Investment Opportunity at Florida Gas, LLC

Florida Gas, LLC is a privately held limited liability corporation. We currently service the Treasure and Gold Coast of Florida. Focused on expansion through acquisitions and internal growth. To learn more about investment opportunities with Florida Gas, LLC, please contact Treasure Coast Private Equity. Q Can common units be purchased directly from Florida Gas? Q What is the difference between a distribution and a dividend? Q HOW DO I GET AN INVESTOR PACKET? Q WHAT IS FLORIDA GAS EXPRESS' CORE BUSINESS?

investors.gilead.com investors.gilead.com

Gilead | Investors | Investor Relations Home

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California. July 28, 2015 -. Gilead Sciences Announces Third Quarter 2015 Dividend. July 28, 2015 -. San Diego, CA. Data collected 08/01/15 - 08/08/15.

investors.gitanjaligroup.com investors.gitanjaligroup.com

Gitanjali Group - Investor Home

Details of Unpaid and Unclaimed Dividend. Stock Quote and Chart. Scrutinizer's Report on E-voting. Voting results for AGM, 2014. Result of Postal Ballot 2013. Results of Ballot with Scrutinizer Report-2014. Draft Scheme of merger of Gitanjali Exports and Corporations Limited (GECL) with Gitanjali Gems Limited (GGL) along with its annexures. Complaints Report Pursuant to the Application Under Clause 24(f) of the Listing Agreement. Observation Letter - NSE. Observation Letter - BSE. Minimum 15 minute delay.

investors.gkservices.com investors.gkservices.com

Investor Relations | G&K Services

Q4 2015 Earnings Conference Call. August 13, 2015. G&K Services is built on a strong business model, characterized by:. High value-added, personalized products and services. Large, attractive market. Significant barriers to entry. Stable, long-term customer contracts. Consistent, strong cash flow. Keep our customer promise. Improve how we target customers. Drive operational excellence, and. Strengthen our high performing team. G&K Services Reports Fiscal 2015 Fourth Quarter Results. G&K Services, Inc.

investors.glaukos.com investors.glaukos.com

Glaukos Corporation - INVESTORS

August 12, 2015. Glaukos Corporation Announces Second Quarter 2015 Financial Results. August 10, 2015. Health Canada Approves the Glaukos iStent inject. August 6, 2015. Glaukos Corporation Announces Completion of Patient Enrollment in U.S. Pivotal Clinical Trial for iStent inject. There are no events scheduled at this time. 26051 Merit Circle, Suite 103. Laguna Hills, CA 92653. Telephone: 949.367.9600 ext 371. Fax: 949.367.9984. 26051 Merit Circle, Suite 103, Laguna Hills, CA 92653.

investors.glpropinc.com investors.glpropinc.com

Investor Relations - Gaming and Leisure Properties, Inc.

Skip to main content. GLPI also intends to diversify its portfolio over time, including by acquiring properties outside the gaming industry to lease to third parties. GLPI intends to elect to be taxed as a real estate investment trust ("REIT") for United States federal income tax purposes commencing with the 2014 taxable year and is the first gaming-focused REIT. August 14, 2015 at 4:00 PM ET. Intraday data provided by eSignal. July 30, 2015. July 30, 2015. July 21, 2015. July 30, 2015 at 9:00 AM ET.

investors.gobio.com investors.gobio.com

BioTelemetry, Inc. – Investor Information – Nasdaq Symbol: BEAT

BioTelemetry, Inc. - Investor Information. BioTelemetry, Inc. (NASDAQ: BEAT). The leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. Error: Embedded data could not be displayed. BioTelemetry, Inc. (NASDAQ: BEAT). Everywhere health goes, we go. The leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care.

investors.godaddy.net investors.godaddy.net

GoDaddy Inc. - Investor Relations - Overview

August 14, 2015. WE LIVE BY THE SAME PRINCIPLES AS ANY SUCCESSFUL STARTUP: HUSTLE, ADAPT, LISTEN. REPEAT. GODADDY ANNOUNCED Q2 2015 EARNINGS ON AUGUST 5, 2015. View PDF (PDF 11.12 MB). At GoDaddy, we're always finding new ways to improve our products, services and overall business. Visit this page often to see how we're expanding our position as an industry leader. August 11, 2015. GoDaddy and Kiva Launch Global Philanthropic Partnership. August 5, 2015. GoDaddy Reports Strong Second Quarter 2015 Results.

investors.goodman.com investors.goodman.com

Investor centre home | GMG investor centre | Goodman

Investor FAQ and glossary. Reports and product information. Goodman is an integrated commercial and industrial property group that owns, develops and manages real estate including warehouses, large scale logistics facilities, business parks and offices globally. Goodman also offers a range of investment property funds, giving investors access to our specialist fund management services and commercial and industrial property assests. Ceasing to be a substantial holder from AMP. View more ASX announcements.

investors.goodtimesburgers.com investors.goodtimesburgers.com

Good Times Burgers & Frozen Custard

The Company owns and operates, and franchises, restaurants in Colorado and Wyoming. We are a quick service restaurant chain serving a high quality, fresh, unique, proprietary selection of hamburgers made with Meyer All-Natural, All-Angus beef, specialty chicken sandwiches, signature Wild Fries and Fresh Cut Fries, Beer Battered Onion Rings and fresh, creamy Frozen Custard in a variety of flavors, sundaes and Spoonbenders. Aug 11, 2015. Good Times Restaurants Reports Q3 Results. Aug 1, 2015.